News | Focused Ultrasound Therapy | April 12, 2017

Theraclion Reports Positive Long-Term Echopulse Results in Breast Fibroadenoma

Study results reveal mean volume reduction at 24 months; treatment is safe and well-tolerated by patients

April 12, 2017 — Theraclion announced results of a study evaluating the long-term assessment of breast fibroadenoma (benign tumor) volume reduction following treatment with the company’s Echopulse, a non-invasive treatment employing ultrasound-guided high-intensity focused ultrasound. The study, entitled “Long-term efficacy of ultrasound-guided high-intensity focused ultrasound (US-guided HIFU) treatment of breast fibroadenoma,” was published online in the March 2017 issue of the Journal of Therapeutic Ultrasound and is available online.

The study assessed a total of 20 female patients with 26 breast fibroadenomas (BFAs) before and for up to 24 months following echotherapy treatment with Echopulse. Nineteen BFAs received a single treatment and seven BFAs a second treatment six to nine months after the initial session. BFA volume was measured by ultrasound. Patient satisfaction on cosmetic results and symptom relief were surveyed and safety and tolerability was recorded. The study demonstrated consistent echotherapy results confirmed at 24 months:

  • Mean BFA volume was significantly reduced by 77.32 percent after a single procedure and by 90.47 percent after two procedures at 24 months follow up;
  • No cases of re-growth of treated lesions were observed during the 24 months follow-up;
  • Treatment was very well-tolerated regardless of whether one or two echotherapy sessions were performed. Side effects were mild and transient and resolved completely; no serious side effects were observed;
  • Of the 20 patients who completed a satisfaction survey, all 20 (100 percent) were completely or highly satisfied with the cosmetic results and 19 of 20 (95 percent) were completely or highly satisfied concerning symptom disappearance; and
  • Authors concluded that “US-guided HIFU represents a promising non-invasive method with sustainable FA volume reduction and patient’s tolerability. Although one treatment is highly efficient, the volume reduction can be increased with second treatment.”

Roussanka Kovatcheva, M.D., professor of endocrinology at the University Hospital of Endocrinology of Sofia, Bulgaria, and Principal Investigator said, “Our results show the long-term efficacy and safety of US-guided HIFU generated by Theraclion’s Echopulse in patients with breast fibroadenomas. US-guided HIFU is definitely an effective non-invasive alternative to surgery enabling more than 90 percent volume reduction without re-growth or serious adverse events.”

For more information: www.jtultrasound.biomedcentral.com

Related Content

First Focused Ultrasound Surgery Performed on Hypothalamic Hamartoma Tumor in Epilepsy Patient
News | Focused Ultrasound Therapy | April 21, 2017
A multidisciplinary clinical team at Nicklaus Children's Hospital used magnetic-resonance guided focused ultrasound – a...
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017
iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft...
3-D-printed Model of Stenotic Intracranial Artery Enables Vessel-Wall MRI Standardization
News | 3-D Printing | April 18, 2017
April 18, 2017 — A collaboration between stroke neurologists at the Medical University of South Carolina (MUSC) and b
3-D Prints Compare Effectiveness of Top Surgical Techniques for Repairing Heel Deformity
News | 3-D Printing | April 18, 2017
Using 3-D models of a patient’s foot, investigators at Cedars-Sinai have found that the three leading procedures for...
University of California Study Searches for Consistent CT Dose Best Practices
News | Radiation Dose Management | April 17, 2017
A new study led by UC San Francisco has found that radiation doses can be safely and effectively reduced – and more...
New MRI Technique Shows Effectiveness of Cystic Fibrosis Drug

Image courtesy of Toshiba Medical.

News | Magnetic Resonance Imaging (MRI) | April 14, 2017
Researchers from the University of Missouri School of Medicine have developed an imaging technique using a specific...
Kentucky and Iowa Enact Breast Density Reporting Legislation
News | Breast Density | April 14, 2017
Kentucky and Iowa both this week joined the ranks of states with laws requiring mammography facilities to inform...
News | Mammography Reporting Software | April 13, 2017
April 13, 2017 — IDS recently announced Women’s Imaging Associates, a premier teleradiology firm located in Birmingha
Study Finds Breast Cancer Rates Increasing Among Asian Americans
News | Women's Health | April 12, 2017
In contrast to other U.S. racial/ethnic groups, Asian Americans have experienced steadily increasing breast cancer...
Parascript and Volpara Establish Partnership for Improved Early Cancer Detection
News | Computer-Aided Detection Software | April 11, 2017
Parascript LLC announced a new partnership with Volpara Solutions, creator of Volpara Density automated breast density...
Overlay Init